Cassava Sciences Inc
Biotechnology
Healthcare
SAVA
48.26 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.70
52 week high
32.18
high
3.66
52 week low
0.00
low
2.54
growth
-88.55 %
previous Close
2.32
P/E ratio
market cap
113 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top